| 摘要 |
The present disclosure relates to the fields of immunology and clinical immunology, and more particularly to the use of B7-family ligands and agonists and antagonists thereof in modulation of immune responses. The invention provides methods for modulation of lymphocyte activation involving the use of B7-H3, including B7-H3 VC and B7-H3 VCVC, and related molecules such as, for example, antibodies and nucleic acids.
|
